Editing
Stones: Epidemiology and Pathogenesis
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Medication associated stones[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1508366] === *'''<span style="color:#0000ff">Lotta Good Drugs Cause Calculi FIT TEST (12):''' *# '''<span style="color:#0000ff">L<span style="color:#ff0000">axatives''' *# '''<span style="color:#0000ff">G<span style="color:#ff0000">uaifenesin''' *# '''<span style="color:#ff0000">Vitamin <span style="color:#0000ff">D''' *# '''<span style="color:#ff0000">Vitamin <span style="color:#0000ff">C</span>''' in high doses is converted to oxalate and may induce hyperoxaluria *# '''<span style="color:#0000ff">C<span style="color:#ff0000">arbonic anhydrase inhibitors''' *#*E.g. acetazolamide *#*May be associated with the formation of calcium-based calculi, '''particularly calcium phosphate''' *# '''<span style="color:#0000ff">F<span style="color:#ff0000">urosemide''' *#* '''Thiazides''' cause intracellular acidosis and '''subsequent hypocitraturia''' *# '''<span style="color:#0000ff">I<span style="color:#ff0000">ndinavir''' *#* '''MOA: protease inhibitor''' *#* '''Used in patients with HIV/AIDS.''' *#* Individuals taking indinavir on a regular basis are at high risk of producing indinavir stones because of the high urinary excretion and poor solubility of the drug at physiologic urinary pH. *#* '''Now infrequently used''', replaced with newer generation agents. Kidney stone formation has been associated with a number of newer anti-retroviral agents. *#* '''Radiolucent on plain film and may not be seen on CT''' *# '''<span style="color:#0000ff">T<span style="color:#ff0000">opiramate''' *#* '''MOA: carbonic anhydrase inhibitor''' *#*Used to treat epilepsy and prevent migraines *#* Creates a chronic intracellular acidosis resulting '''in a urinary milieu similar to distal RTA''' with hyperchloremic acidosis, high urine pH, extremely low urinary citrate, and hypercalciuria. *#* '''Treatment may be potassium citrate''' or cessation of the medication if possible. *# '''<span style="color:#0000ff">T<span style="color:#ff0000">riamterene''' *#* '''MOA: potassium-sparing diuretic''' *#* Used for the treatment of hypertension *#* '''Radiolucent''' *# '''<span style="color:#0000ff">E<span style="color:#ff0000">phedrine''' *# '''<span style="color:#0000ff">S<span style="color:#ff0000">ilicates''' *# '''<span style="color:#0000ff">T<span style="color:#ff0000">MP/SMX'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information